Archived Newsletters
-
07.08.26 -- Rethinking Biotech Growth: Is More Capital the Answer?
7/8/2026
07/08/26 Outsourced Pharma Newsletter
-
07.07.26 -- Advancing Microbial Manufacturing And ADCs With CDMO Expertise
7/7/2026
07/07/26 Outsourced Pharma Newsletter
-
07.07.26 -- How Kodak Reimagined Its Film Infrastructure For Biopharma Manufacturing
7/7/2026
07/07/26 Outsourced Pharma Newsletter
-
07.06.26 -- STREAM Early Phase Drug Development
7/6/2026
07/06/26 Outsourced Pharma Newsletter
-
07.06.26 -- Overcoming The Hurdles Of Cell And Gene Therapy Commercialization
7/6/2026
07/06/26 Outsourced Pharma Newsletter
-
07.03.26 -- Oligonucleotide Scale-Up: Six Things Every Sponsor Needs To Know
7/3/2026
07/03/26 Outsourced Pharma Newsletter
-
07.02.26 -- New Podcast Episodes: A Midyear Look At Life Sciences, Derisking CNS Drug Development, In Vivo Gene Editing
7/2/2026
07/02/26 Outsourced Pharma Newsletter
-
07.02.26 -- The Mindset Shift Your Biopharma Outsourcing Strategy Is Missing
7/2/2026
07/02/26 Outsourced Pharma Newsletter
-
07.01.26 -- Insights Into How Sponsors Search Today For CDMOs
7/1/2026
07/01/26 Outsourced Pharma Newsletter
-
06.30.26 -- The BIOSECURE Act Debate: Why The Industry Still Can't Agree On WuXi
6/30/2026
06/30/26 Outsourced Pharma Newsletter